arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Atara Biotherapeutics, Inc.

ATRA

$8.47 ▲ +0.27 (+3.29%) at close

14 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bullish

auto_awesome

Analytical Summary

Atara Biotherapeutics, Inc. demonstrates solid fundamentals with strength in Profit Margin (%). However, watch Return on Common Equity (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $106.2M

Dividend Yield —

Revenue Growth -6.3% ↘

Op. Margin 29.7% ↗

ROIC -93.1% ↘

FCF / Share $-4.06 ↗

Trailing P/E 3.3x

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$120.77M

↓ -6.3% —

Net Income Profit after all expenses

$32.69M

↑ +138.3% —

Operating Margin Operating profit as % of sales

29.7%

↑ +145.9% 86th

FCF / Share Free cash flow per share

$-4.06

↑ +55.9% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	-6.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-179%)	1404.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+17450%)	-86.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1181%)	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	82.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2810.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	38.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	69.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-20.9% Weak ↓ Weak Declining Year-over-year change in net income	32.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-10.9% Weak ↑ Weak Improving Year-over-year change in net income	-5.4% Weak ↑ Weak Improving Year-over-year change in net income	-26.1% Weak ↑ Weak Improving Year-over-year change in net income	-93.1% Weak ↓ Weak Declining Year-over-year change in net income	-51.2% Weak ↑ Weak Improving Year-over-year change in net income	-38.1% Weak ↑ Weak Improving Year-over-year change in net income	-104.3% Weak Weak Year-over-year change in net income	-219.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	55.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	79.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-1602.6% Weak Weak Year-over-year change in free cash flow	-9.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	23.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	29.7% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+98%)	-64.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-531%)	—	-441.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3042%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	27.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+126%)	-66.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-652%)	—	-359.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3093%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-42.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-53.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-432.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	-1.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.20x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-93.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	85.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	278.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-221.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-121.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-101.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-70.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	79.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	177.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-76.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-166.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-74.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-52.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-86.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-60.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-55.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-16.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-84.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-666%)	87.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+485%)	278.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1755%)	-180.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1302%)	-121.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-911%)	-66.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-542%)	-100.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-767%)	-68.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-554%)	-67.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-548%)	-31.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-308%)	-18.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-27.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	79.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+431%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Interest Coverage (x)	9.46x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	-18.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-52.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-752.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10639.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4984.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5913.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	-987.96x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-8.48M	$-25.03M	$-25.84M	$-92.94M	$-106.08M	$-200.40M	$-74.32M	$-60.70M	$-79.22M	$-47.97M	$-23.75M	$-21.90M	$-51.62M	$-4.21M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	$9.63	$17.22	$2.02	$0.62	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$2.61	$-11.41	$-65.19	$-2.24	$-3.63	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-4.06	$-9.21	$-45.85	$-2.69	$-2.47	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-5.26	$-16.60	$-23.30	$1.32	$3.05	$5.55	$5.12	$7.37	$5.79	$8.77	$11.07	$5.24	$-0.92	—
Tangible Book Value per Share (USD)	$-5.26	$-16.60	$-23.30	$1.32	$3.05	$5.55	$5.12	$7.37	$5.79	$8.77	$11.07	$5.24	$-0.92	—
Basic Weighted Avg Shares (shares)	12.54M	7.49M	4.24M	101.99M	93.67M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$-2.71M	$-69.68M	$-40.36M	$216.16M	$278.83M	$440.37M	$236.25M	$281.51M	$144.54M	$250.88M	$314.89M	$103.30M	$50.28M	—
Total Equity (USD)	$-38.50M	$-97.28M	$-99.23M	$126.64M	$279.61M	$462.34M	$290.78M	$338.86M	$177.86M	$253.74M	$315.10M	$103.18M	$-11.02M	$-3.73M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$120.77M	$128.94M	$8.57M	$63.57M	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$400.00K	$2.70M	$3.70M	$4.70M	—	—	—	—	—	—	$48.00K	$6.00K	$4.00K	—
Net Income, GAAP (USD)	$32.69M	$-85.40M	$-276.13M	$-228.30M	$-340.14M	$-306.62M	$-290.98M	$-230.70M	$-119.49M	$-79.05M	$-57.22M	$-28.01M	$-8.77M	—
Operating Cash Flow (USD)	$-50.94M	$-68.72M	$-192.98M	$-270.43M	$-220.52M	$-180.76M	$-235.63M	$-179.77M	$-87.50M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 53 quarters

Atara Biotherapeutics, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ATRA with peers